ADVAX

BIOLOGICAL2 trials

Sponsors

International AIDS Vaccine Initiative

Conditions

HIV InfectionHIV Infections

Phase 1

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults

CompletedNCT00249106

International AIDS Vaccine InitiativeHIV Infection

Start: 2003-12-31End: 2005-10-31Updated: 2013-02-11

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

CompletedNCT00902824

International AIDS Vaccine InitiativeHIV Infections

Start: 2008-11-30End: 2010-04-30Updated: 2013-02-11

Related Papers

Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.

2010-01-2534 citations